
Marco Metra
Latest contributions
Tricuspid regurgitation and heart failure with preserved ejection fraction
11 Jun 2025
Watch the replay of this webinar with M. Adamo, M. Metra, K-P. Kresoja, P. Lurz, P. Ponikowski and M. Sitges and learn about mechanisms and risk factors for HFpEF and TR, and so much more!

When mitral disease is not the only problem on mitral TEER patients
22 May 2025 – From EuroPCR 2025
Explore the multifaceted challenges in patients undergoing mitral TEER when additional mitral and tricuspid pathologies coexist. This session reviews data from the EXPANDed studies on tricuspid regurgitation post-mitral TEER, one-year outcomes based on cardiac damage extent, pulmonary hypertension dynamics, and the long-term mortality causes in this...

Tricuspid hotline: new devices
22 May 2025 – From EuroPCR 2025
Discover cutting-edge developments in transcatheter tricuspid valve replacement with new device technologies. Review first-in-human trials, early outcomes from multicenter studies, and innovative designs that promise to advance tricuspid regurgitation treatment.

Electrosurgical techniques in transcatheter mitral valve replacement
22 May 2025 – From EuroPCR 2025
Delve into electrosurgical techniques in transcatheter mitral valve replacement. This session covers advanced methods including the tip-to-base lampoon technique, electrosurgical laceration of failed devices, left ventricular outflow tract obstruction management, combined septal ablation and valve-in-valve procedures, and management of severe aortic regurgitation post-laceration.

Tricuspid valve intervention in complex scenarios - Patient and procedural optimisation
20 Nov 2023 – From PCR London Valves 2023
Watch this session to enhance your knowledge on optimizing patients throughout the entire transcatheter tricuspid valve intervention process— from pre-procedure preparation to post-procedural care. Learn effective strategies for managing immediate and early complications, refine post-procedural treatment plans, and gain insights into future strategies aimed at further...

20 years of TEER: a journey at the crossroads of the human heart
20 Nov 2023 – From PCR London Valves 2023
In 2023, with 200,000 MitraClips performed, the session concluded by posing the question of how many M-TEERs would be conducted by 2026. While the answer remains a mystery until PCR LV 2026, explore the fascinating history of transcatheter edge-to-edge mitral valve repair in this session. Delve...

Tricuspid valve intervention in complex scenarios - Tackling tricuspid regurgitation using a multidisciplinary approach
20 Nov 2023 – From PCR London Valves 2023
This session explores the diverse phenotypes of tricuspid regurgitation patients, emphasizing the clinical implications and advocating for a multidisciplinary approach to assessment and treatment. It covers TR clinical courses, investigation pathways, and case scenarios, including atrial fibrillation, heart failure (preserved and reduced ejection fraction), pulmonary hypertension,...

The TRILUMINATE pivotal trial: impact on practice and perspectives
19 Jul 2023
Watch the replay of this webinar with F. Praz, F. Maisano, V. Delgado, R. Hahn, M. Metra and P. Sorajja and learn about the latest randomised results on the treatment of tricuspid regurgitation and so much more!

PCR Tricuspid Focus Group - referral meeting in Milan
10 Jul 2023
Join your peers for this meeting on 13-14 January 2025 in Milan, Italy!

Management of tricuspid regurgitation and heart failure
14 Feb 2023
Watch the replay of the 1st webinar on Tricuspid valve disease: patient pathways. You’ll learn all about 'Management of tricuspid regurgitation and heart failure'

How should we optimally manage mitral and tricuspid regurgitation – the Heart Team approach
15 Dec 2020
Watch the replay of this webinar on transcatheter management of mitral and tricuspid regurgitation with M.Metra, B. Prendergast, H. Treede and R. S. Von Bardeleben.

Natural history and prognosis of tricuspid valve disease
04 Aug 2022
PCR Webinar with M. Metra, F. Praz, M. Sitges, E. Donal, R. Hahn, D. Muraru and Y. Topilsky

New 2021 ESC heart failure and valvular heart diseases guidelines : impact on secondary mitral regurgitation management
21 Nov 2021 – From PCR London Valves 2021
Join Ralph Stephan Von Bardeleben and Marco Metra if you want to learn about the new ESC 2021 guidelines in heart failure management and the key interconnections between the heart failure and the valvular heart diseases guidelines, as well as to understand how this will improve...

#1 - Natural history and prognosis of tricuspid valve disease
23 Sep 2021
PCR Webinar with M. Metra, F. Praz, M. Sitges, E. Donal, R. Hahn, D. Muraru and Y. Topilsky

How should we optimally manage mitral and tricuspid regurgitation – the Heart Team approach
22 Feb 2021
[WATCH] - PCR Webinar with M.Metra, B. Prendergast, H. Treede and R. S. Von Bardeleben.

Controversy - Challenges for the Heart Team II - Mitral regurgitation and heart failure - Where two worlds meet
19 Nov 2019 – From PCR London Valves 2019
Consult this session on mitral regurgitation and heart failure to hear the latest thinking concerning the optimal management of patients suffering from these diseases, and discover the implications of recent trials for your clinical practice, such as COAPT, MITRA-FR, and more!

The Edwards PASCAL transcatheter valve repair system - Latest innovation in transcatheter mitral valve therapy
19 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about the PASCAL repair system, and discover the essential role of imaging in planning and performing a successful PASCAL repair system procedure thanks to a variety of clinical cases.

Mitral regurgitation: a comprehensive patient-based approach
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about the pathophysiology of mitral regurgitation, and discover its implications for device design, selection and durability, which imaging modality is the most relevant to clinical decision-making, and how Heart Team working can provide the best treatment option for complex patients.

Introduction to the PCR London Valves 2019 Mitral and Tricuspid track - The key questions in mitral and tricuspid valve interventions: where are we in 2019?
18 Nov 2019 – From PCR London Valves 2019
Consult this session to appreciate the critical importance of the Heart Team in identifying the optimal treatment strategy for patients with mitral and tricuspid valve disease, and to learn more about the challenges of transcatheter mitral and tricuspid valve interventions and the complexities associated with patient and device...
